Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? reply

被引：2

作者：

Weidhaas, Joanne ^{[1
]}

Slack, Frank ^{[2
]}

Miller, Nicola ^{[7
]}

Harris, Lyndsay ^{[3
]}

Tuck, David ^{[4
]}

Zhu, Yong ^{[5
]}

Zelterman, Daniel ^{[5
]}

Kerin, Michael ^{[7
]}

Paranjape, Trupti ^{[1
]}

Heneghan, Helen ^{[7
]}

Lindner, Robert ^{[8
]}

Keane, Florence ^{[6
]}

Dorairaj, Jemima ^{[7
]}

Geyda, Kimberly ^{[3
]}

Pelletier, Cory ^{[1
]}

Nallur, Sunitha ^{[1
]}

机构：

[1] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA

[2] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA

[3] Yale Univ, Dept Med Oncol, New Haven, CT USA

[4] Yale Univ, Dept Pathol, New Haven, CT USA

[5] Yale Univ, Dept Publ Hlth, New Haven, CT USA

[6] Yale Univ, Yale Med Sch, New Haven, CT USA

[7] Natl Univ Ireland, Inst Clin Sci, Dept Surg, Galway, Ireland

[8] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany

来源：

LANCET ONCOLOGY | 2011年 / 12卷 / 08期

关键词：

D O I：

10.1016/S1470-2045(11)70163-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：724 / 724

页数：1

共 50 条

[41] Association between IDO1 expression and pCR rate in triple-negative breast cancer
Vtorushin, S.
Naumov, S.
Taranenko, M.
Krakhmal, N.
VIRCHOWS ARCHIV, 2024, 485 : S209 - S209
[42] The association of androgen receptor with microRNA expression in triple-negative breast cancer
Abu Alragheb, Bayan O.
Abushukair, Hassan
Al-Husseini, Maysa
Bawadi, Randa
Ahram, Mamoun
CANCER RESEARCH, 2023, 83 (07)
[43] KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA)
Berchuck, A.
van der Baan, F. H.
Johnatty, S. E.
Chenevix-Trench, G.
Pharoah, P. D. P.
Rookus, M. A.
Goode, E.
GYNECOLOGIC ONCOLOGY, 2015, 137 : 26 - 27
[44] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer REPLY
Schmid, Peter
Chui, Stephen Y.
Emens, Leisha A.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 987 - 988
[45] Triple-Negative and Non-Triple-Negative Invasive Breast Cancer: Association between MR and Fluorine 18 Fluorodeoxyglucose PET Imaging
Bolouri, Marjan S.
Elias, Sjoerd G.
Wisner, Dorota J.
Behr, Spencer C.
Hawkins, Randall A.
Suzuki, Sachiko A.
Banfield, Krysta S.
Joe, Bonnie N.
Hylton, Nola M.
RADIOLOGY, 2013, 269 (02) : 353 - 360
[46] A retrospective comparison of the characteristics and recurrence outcome of triple-negative and triple-positive breast cancer
Randhawa, Jaskirat Singh
Venur, Vyshak Alva
Kawsar, Hameem
Spiro, Timothy Peter
Haddad, Abdo S.
Bagai, Rajesh Kumar
Daw, Hamed
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[47] Neoadjuvant chemotherapy in HER2-positive and triple-negative breast cancer
Goncalves, Anthony
BULLETIN DU CANCER, 2016, 103 (06) : S76 - S89
[48] The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
Lei Zhang
Ru Tang
Jia-Peng Deng
Wen-Wen Zhang
Huan-Xin Lin
San-Gang Wu
Zhen-Yu He
BMC Cancer, 20
[49] Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype
Laranjo, Mafalda
Carvalho, Maria Joao
Costa, Tania
Alves, Andre
Oliveira, Rui Caetano
Casalta-Lopes, Joao
Cordeiro, Patricia
Botas, Filomena
Abrantes, Ana Margarida
Paiva, Artur
Oliveira, Carlos
Botelho, Maria Filomena
BREAST, 2018, 38 : 22 - 29
[50] The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
Zhang, Lei
Tang, Ru
Deng, Jia-Peng
Zhang, Wen-Wen
Lin, Huan-Xin
Wu, San-Gang
He, Zhen-Yu
BMC CANCER, 2020, 20 (01)

← 1 2 3 4 5 →